Pharmaceutical - Immunologicals, Novartis

Filter

Current filters:

ImmunologicalsNovartis

Popular Filters

Novartis enters into a collaboration for Il-17 inhibitor

06-08-2013

US biotech firm Ensemble Therapeutics, a company developing Ensemblins, a novel class of small molecule…

BiotechnologyEnsemble TherapeuticsImmunologicalsInflammatory diseasesLicensingNovartisPharmaceutical

Novartis' Zortress first drug in over a decade approved by FDA to prevent organ rejection

18-02-2013

Swiss drug major Novartis (NOVN: VX) said on Friday that the US Food and Drug Administration has approved…

ImmunologicalsNorth AmericaNovartisPharmaceuticalRegulationZortress

Novartis/Vectura's QVA149 is filed as a treatment for COPD in Europe; Certican EU approval

26-10-2012

The UK's Vectura Group (LSE: VEC) confirmed that its partner, Swiss drug giant Novartis (NOVN: VX) has…

CerticanEuropeFinancialImmunologicalsNovartisPharmaceuticalQVA149RegulationResearchRespiratory and PulmonaryVectura

Back to top